Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19
Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19
Veru 的目標價格從 Cantor Fitzgerald 的 24 美元上調至 30 美元,理由是薩比扎布林提交了治療 COVID-19 的緊急使用許可
Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19
Veru 的目標價格從 Cantor Fitzgerald 的 24 美元上調至 30 美元,理由是薩比扎布林提交了治療 COVID-19 的緊急使用許可